Oseltamivir vs Tofacitinib
Oseltamivir vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Oseltamivir and Tofacitinib.
Mechanism of Action
Oseltamivir: Neuraminidase inhibitor preventing viral release from host cells.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Oseltamivir — 6-10 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Oseltamivir — C16H28N2O4; Tofacitinib — C16H20N6O.
Molecular Weight: Oseltamivir — 312.4050 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Oseltamivir — Small molecule; Tofacitinib — Small molecule.